154TiP TACTIVE-N: Open-label, randomized, noncomparative neoadjuvant phase 2 study of ARV-471, a PROteolysis TArgeting Chimera (PROTAC) estrogen receptor (ER) degrader, or anastrozole in postmenopausal women with ER+/human epidermal growth factor receptor 2 (HER2)- localized breast cancer
Fasching, P.A., Clifton, K., Katashvili, Z., Nemsadze, G., Makharadze, T., Arkania, E., Gogishvili, M., Lachowicz, M., Gedrich, R., Ranciato, J., Zhi, E., Perkins, J., Jañez, N. Martinez, Hurvitz, S.A.
Published in ESMO open (01.05.2023)
Published in ESMO open (01.05.2023)
Get full text
Journal Article
Complex treatment of mastopathy patients with concomitant diseases
Katashvili, Z, Nemsadze, G, Gvamichava, P, Vekua, N, Nemsadze, D
Published in Georgian medical news (01.10.2007)
Get more information
Published in Georgian medical news (01.10.2007)
Journal Article